Update of USP Chapter <1099> on Content Uniformity in Large Samples
Recommendation

Monday, 21 September 2026 14.00 - 16.00 h
Regulatory Landscape: ECHA, USP, Pharmacopoeias and FDA Enforcement
In the current Pharmacopeial Forum, PF 51(3), the USP has published a revised draft of General Chapter <1099> Limit on Number of Large Deviations When Assessing Content Uniformity in Large Samples.
The briefing notes state the following: "This proposal is based on the version of the chapter official as of March 1, 2019. On the basis of comments received, the proposal published in PF 47(4) [Jul. –Sep. 2021] has been canceled and is being replaced with this new proposal. It seeks to clarify that <1099> is not linked to Uniformity of Dosage Units <905>. It also includes new Table 2 and moves the statistical formulas to an Appendix."
The draft provides a statistical method to assess large data sets using a zero-tolerance criterion (ZTC). New procedures and tables are introduced, allowing manufacturers to evaluate whether a large sample complies with target limits on deviations, especially when sample sizes exceed 30 units. The revised version introduces a flexible approach based on confidence intervals, particularly using Jeffreys’ method, to determine acceptable levels of variation.
The new draft can be viewed on the Pharmacopeial Forum website. The comment period is open until 31 July 2025.
Related GMP News
03.09.2026USP Article: Supporting the Detection of Asbestos in Pharmaceutical Talc
02.09.2026USP Publishes Comments Received on Chapter <320>
26.08.2026New USP Requirements for Asbestos Testing in Pharmaceutical Talc
19.08.2026FDA Warning Letter: Averaging Data to Override OOS Findings
12.08.2026ECA's Analytical Control Group Publishes Detailed Report on OOS Survey
12.08.2026BP Publishes Key Insights on Limits in Chromatographic Tests


